JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4076
Geron
GERN
$777M
| $461K | ﹤0.01% |
277,972
-2,744,996
| -91% | -$3.75M |
2014 Q4
17 quarters
|
|
|
TRTN
4077
DELISTED
Triton International Limited
TRTN
| $461K | ﹤0.01% |
14,830
-345
| -2% | -$11.5K |
2017 Q4
5 quarters
|
|
|
HIO
4078
Western Asset High Income Opportunity Fund
HIO
$308M
| $460K | ﹤0.01% |
95,245
| – | – |
2016 Q4
9 quarters
|
|
4079
German American Bancorp
GABC
$1.85B
| $459K | ﹤0.01% |
15,609
+181
| +1% | +$5.47K |
2013 Q2
23 quarters
|
|
4080
Pricesmart
PSMT
$5.3B
| $458K | ﹤0.01% |
7,767
-315
| -4% | -$19.7K |
2015 Q4
13 quarters
|
|
4081
CNA Financial
CNA
$12.5B
| $457K | ﹤0.01% |
10,542
-5,373
| -34% | -$238K |
2015 Q2
15 quarters
|
|
|
QHC
4082
DELISTED
Quorum Health Corporation
QHC
| $457K | ﹤0.01% |
326,394
-344,363
| -51% | -$927K |
2016 Q2
11 quarters
|
|
4083
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$880M
| $454K | ﹤0.01% |
23,000
-110
| -0.5% | -$2.12K |
2018 Q3
2 quarters
|
|
4084
Andersons Inc
ANDE
$2.27B
| $453K | ﹤0.01% |
14,048
-4,624
| -25% | -$160K |
2013 Q2
23 quarters
|
|
4085
Renasant Corp
RNST
$3.62B
| $453K | ﹤0.01% |
13,390
+342
| +3% | +$12.2K |
2016 Q4
9 quarters
|
|
4086
MaxLinear
MXL
$9.57B
| $450K | ﹤0.01% |
17,610
-537
| -3% | -$11.7K |
2016 Q2
11 quarters
|
|
|
CBIO
4087
CALL
Crescent Biopharma
CBIO
$518M
| $449K | ﹤0.01% |
+360
| New | +$412K |
2019 Q1
0 quarters
|
|
|
CBIO
4088
PUT
Crescent Biopharma
CBIO
$518M
| $449K | ﹤0.01% |
+360
| New | +$412K |
2019 Q1
0 quarters
|
|
|
I
4089
DELISTED
INTELSAT S. A.
I
| $449K | ﹤0.01% |
28,662
-479,004
| -94% | -$10.2M |
2017 Q4
5 quarters
|
|
4090
Eagle Bancorp
EGBN
$863M
| $446K | ﹤0.01% |
8,878
-9,584
| -52% | -$523K |
2017 Q4
5 quarters
|
|
4091
First Trust Financials AlphaDEX Fund
FXO
$1.04B
| $446K | ﹤0.01% |
14,725
+56
| +0.4% | +$1.68K |
2013 Q2
23 quarters
|
|
|
TAST
4092
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $446K | ﹤0.01% |
44,679
-2,370
| -5% | -$23.1K |
2017 Q4
5 quarters
|
|
|
GTT
4093
PUT
DELISTED
GTT Communications, Inc.
GTT
| $441K | ﹤0.01% |
12,700
-11,100
| -47% | -$326K |
2018 Q3
2 quarters
|
|
|
IBTX
4094
DELISTED
Independent Bank Group, Inc.
IBTX
| $441K | ﹤0.01% |
8,611
+3,058
| +55% | +$165K |
2017 Q4
5 quarters
|
|
4095
iShares US Oil Equipment & Services ETF
IEZ
$357M
| $439K | ﹤0.01% |
17,392
-17,636
| -50% | -$434K |
2013 Q2
23 quarters
|
|
|
LBRDA
4096
DELISTED
Liberty Broadband Class A
LBRDA
| $439K | ﹤0.01% |
4,787
+1,035
| +28% | +$87.9K |
2014 Q4
17 quarters
|
|
4097
Stantec
STN
$7.52B
| $437K | ﹤0.01% |
18,478
-2,758
| -13% | -$65.4K |
2018 Q1
4 quarters
|
|
4098
United States Natural Gas Fund
UNG
$476M
| $436K | ﹤0.01% |
4,645
-50,427
| -92% | -$5.04M |
2013 Q2
23 quarters
|
|
|
AEGN
4099
DELISTED
Aegion Corp
AEGN
| $436K | ﹤0.01% |
24,762
-108,806
| -81% | -$1.97M |
2013 Q2
23 quarters
|
|
|
EBIX
4100
DELISTED
Ebix Inc
EBIX
| $436K | ﹤0.01% |
8,829
+66
| +0.8% | +$3.48K |
2016 Q4
9 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.